Novavax (NVAX) Common Equity (2010 - 2026)
Novavax (NVAX) recorded Common Equity of -$190.71 million in Q2 2026, compared with $37.63 million a year earlier.
Powered by 
Analysis
Novavax (NVAX) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax reported Common Equity of -$127.75 million.
- Across earlier years, Common Equity came in at -$623.84 million in FY2024, -$716.93 million in FY2023, -$634.08 million in FY2022 and -$351.67 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Common Equity since Q4 2024.
- Per Business Quant, the preceding three quarters came in at -$144.76 million (Q1 2026), -$127.75 million (Q4 2025) and -$156.67 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn | -216.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -216.86 Mn |
| Jun 30, 2026 | -190.71 Mn |
| Mar 31, 2026 | -144.76 Mn |
| Dec 31, 2025 | -127.75 Mn |
| Sep 30, 2025 | -156.67 Mn |
| Jun 30, 2025 | 37.63 Mn |
| Mar 31, 2025 | -75.64 Mn |
| Dec 31, 2024 | -623.84 Mn |
| Sep 30, 2024 | -526.44 Mn |
| Jun 30, 2024 | -431.71 Mn |
| Mar 31, 2024 | -867.08 Mn |
| Dec 31, 2023 | -716.93 Mn |
| Sep 30, 2023 | -678.35 Mn |
| Jun 30, 2023 | -754.52 Mn |
| Mar 31, 2023 | -895.58 Mn |
| Dec 31, 2022 | -634.08 Mn |
| Sep 30, 2022 | -565.99 Mn |
| Jun 30, 2022 | -416.95 Mn |
| Mar 31, 2022 | 65.32 Mn |
| Dec 31, 2021 | -351.67 Mn |
API Access
Novavax Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();